Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Healthcare Nanotechnology and Nanomedicine Therapeutics
The 2025-2030 World Outlook for Healthcare Nanotechnology and Nanomedicine Therapeutics This study covers the world outlook for healthcare nanotechnology and nanomedicine therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More
-
The 2025-2030 World Outlook for Critical Care Albumin Therapeutics
The 2025-2030 World Outlook for Critical Care Albumin Therapeutics This study covers the world outlook for critical care albumin therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Insomnia Therapeutics
The 2025-2030 World Outlook for Insomnia Therapeutics This study covers the world outlook for insomnia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Arthiritis Therapeutics
The 2025-2030 World Outlook for Arthiritis Therapeutics This study covers the world outlook for arthiritis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Multiple Sclerosis Therapeutics
The 2025-2030 World Outlook for Multiple Sclerosis Therapeutics This study covers the world outlook for multiple sclerosis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Orphan and Rare Dermatology Therapeutics
The 2025-2030 World Outlook for Orphan and Rare Dermatology Therapeutics This study covers the world outlook for orphan and rare dermatology therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Therapeutics for Narcolepsy with Cataplexy
The 2025-2030 World Outlook for Therapeutics for Narcolepsy with Cataplexy This study covers the world outlook for therapeutics for narcolepsy with cataplexy across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Post-Exposure Prophylaxis Rabies Treatments
The 2025-2030 World Outlook for Post-Exposure Prophylaxis Rabies Treatments This study covers the world outlook for post-exposure prophylaxis rabies treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Chemotherapy Therapeutics
The 2025-2030 World Outlook for Colorectal Cancer Chemotherapy Therapeutics This study covers the world outlook for colorectal cancer chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies This study covers the world outlook for alpha-1 antitrypsin deficiency treatment augmentation therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, o ... Read More
-
The 2025-2030 World Outlook for Lysosomal Disease Treatments
The 2025-2030 World Outlook for Lysosomal Disease Treatments This study covers the world outlook for lysosomal disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Lysosomal Storage Diseases Treatments
The 2025-2030 World Outlook for Lysosomal Storage Diseases Treatments This study covers the world outlook for lysosomal storage diseases treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Oral Alopecia Drugs
The 2025-2030 World Outlook for Oral Alopecia Drugs This study covers the world outlook for oral alopecia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Systemic Psoriasis Therapeutics
The 2025-2030 World Outlook for Systemic Psoriasis Therapeutics This study covers the world outlook for systemic psoriasis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Metabolic Disorder Therapeutics
The 2025-2030 World Outlook for Metabolic Disorder Therapeutics This study covers the world outlook for metabolic disorder therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Antiviral Drugs
The 2025-2030 World Outlook for Antiviral Drugs This study covers the world outlook for antiviral drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Biosimulation Technologies
The 2025-2030 World Outlook for Biosimulation Technologies This study covers the world outlook for biosimulation technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Thrombin
The 2025-2030 World Outlook for Thrombin This study covers the world outlook for thrombin across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent ... Read More
-
The 2025-2030 World Outlook for Leukemia Treatments
The 2025-2030 World Outlook for Leukemia Treatments This study covers the world outlook for leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for HIV-1 Therapeutics
The 2025-2030 World Outlook for HIV-1 Therapeutics This study covers the world outlook for HIV-1 therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Lipopeptide MRSA Drugs
The 2025-2030 World Outlook for Lipopeptide MRSA Drugs This study covers the world outlook for lipopeptide MRSA drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Respiratory Complications Therapeutics
The 2025-2030 World Outlook for Respiratory Complications Therapeutics This study covers the world outlook for respiratory complications therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Substance Abuse Treatments
The 2025-2030 World Outlook for Substance Abuse Treatments This study covers the world outlook for substance abuse treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Leukemia Chemotherapy Therapeutics
The 2025-2030 World Outlook for Leukemia Chemotherapy Therapeutics This study covers the world outlook for leukemia chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Xerostomia Therapeutics
The 2025-2030 World Outlook for Xerostomia Therapeutics This study covers the world outlook for xerostomia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
Research Assistance
